https://www.hcplive.com/view/empagliflozin-provides-consistent-benefit-in-hfref-regardless-of-diuretic-use
0
0
9/15/23 at 3:00pm
Organization
Hcplive.com
Author
Patrick Campbell
44 words
0
Comments
Data from the EMPEROR-Reduced trial provide insight into the effects of empagliflozin in patients with heart failure with reduced ejection fraction based on baseline diuretic use from the phase 3 trial.
You are the first to view
Create an account
or login to join the discussion